Bio-Techne
TECH
#1680
Rank
HK$77.49 B
Marketcap
HK$490.22
Share price
-1.96%
Change (1 day)
-16.56%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total assets

Total assets on the balance sheet as of December 2024 : HK$20.74 Billion

According to Bio-Techne's latest financial reports the company's total assets are HK$20.74 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Bio-Techne - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2024-06-30HK$21.11 B2.08%
2023-06-30HK$20.68 B14.88%
2022-06-30HK$18.00 B2.49%
2021-06-30HK$17.56 B11.8%
2020-06-30HK$15.71 B6.73%
2019-06-30HK$14.72 B17.75%
2018-06-30HK$12.50 B2.82%
2017-06-30HK$12.16 B38.75%
2016-06-30HK$8.76 B6.32%
2015-06-30HK$8.24 B23.3%
2014-06-30HK$6.68 B10.77%
2013-06-30HK$6.03 B8.16%
2012-06-30HK$5.58 B16.1%
2011-06-30HK$4.80 B18.96%
2010-06-30HK$4.04 B10.46%
2009-06-30HK$3.65 B-7.53%
2008-06-30HK$3.95 B11.27%
2007-06-30HK$3.55 B23.6%
2006-06-30HK$2.87 B25.37%
2005-06-30HK$2.29 B-9.6%
2004-06-30HK$2.53 B23.62%
2003-06-30HK$2.05 B10.48%
2002-06-30HK$1.85 B10.53%
2001-06-30HK$1.68 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
HK$755.96 B 3,544.41%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$72.73 B 250.66%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$424.62 B 1,947.06%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$602.32 B 2,803.74%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$48.70 B 134.80%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
HK$956.51 B 4,511.26%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$0.58 B-97.18%๐Ÿ‡บ๐Ÿ‡ธ USA